Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma
Abstract Liver cancer, notably hepatocellular carcinoma (HCC), poses a significant global health burden due to its high fatality rates. Conventional antitumor medications face challenges, including poor targeting, high toxicity, and drug resistance, leading to suboptimal clinical outcomes. This revi...
Saved in:
| Main Authors: | Xianzhe Yu, Qin Zhang, Leibo Wang, Yan Zhang, Lingling Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-025-00658-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in nanoparticles in targeted drug delivery–A review
by: Safiul Islam, et al.
Published: (2025-05-01) -
A metal-drug self-delivery nanomedicine alleviates tumor immunosuppression to potentiate synergistic chemo/chemodynamic therapy against hepatocellular carcinoma
by: Chen Guo, et al.
Published: (2025-07-01) -
A Narrative Review on Functionalized Nanoparticles for the Treatment and Early Detection of Hepatocellular Carcinoma
by: Meda Cosma, et al.
Published: (2025-07-01) -
Nanoparticles and the treatment of hepatocellular carcinoma
by: Zhang Ziyu, et al.
Published: (2024-12-01) -
Targeted treatment of hepatocellular carcinoma with aptamer-guided solid lipid nanoparticles loaded with norcantharidin
by: Yilin Xu, et al.
Published: (2025-12-01)